中财网 中财网股票行情
恒瑞医药(600276)财务分析指标    年份：
截止日期2025-09-302025-06-302025-03-312024-12-312024-09-30
营业总收入(万元)2318808.191576119.36720561.112798460.532018930.38
营业收入(万元)2318808.191576119.36720561.112798460.532018930.38
营业总成本(万元)1694966.541089980.16512854.182101154.141508997.92
营业成本(万元)319544.12211496.22106866.25384817.74283318.27
净利润(万元)577085.74447655.04187650.22633417.49460807.66
归属于母公司的净利润(万元)575116.95445010.64187405.55633652.70461957.59
营业利润(万元)662451.24515889.27208598.09749063.20534529.05
利润总额(万元)641200.78505093.42207560.37716969.00508674.02
少数股东损益(万元)906.56456.43238.6446.76-324.57
基本每股收益(元)0.89(元)0.70(元)0.30(元)1.00(元)0.73(元)
稀释每股收益(元)0.89(元)0.70(元)0.30(元)1.00(元)0.73(元)
非经常性损益(万元)16181.98--1076.8915856.05--
扣除非经常性损益后净利润(万元)558934.97427284.85186328.66617796.65461631.48
总资产(万元)6832754.056289351.715129278.175013564.534833809.94
总负债(万元)829502.25386371.91374301.26404539.46400658.07
归属于母公司股东权益合计(万元)5950425.085846483.124698705.954551986.194376790.88
股东权益合计(万元)6003251.805902979.804754976.914609025.074433151.87
实收资本(股本)(万元)663719.99663719.99637900.23637900.23637900.23
资本公积(万元)1293203.731287149.67285387.48318807.26322235.23
未分配利润(万元)3834256.843704150.523573958.453386552.903214857.79
经营活动产生的现金流量净额(万元)911043.03430045.3355517.41742275.30458544.60
经营活动现金流入小计(万元)2697282.281612379.40630193.652846888.172054679.71
经营活动现金流出小计(万元)1786239.251182334.08574676.242104612.871596135.11
投资活动产生的现金流量净额(万元)-152626.69-108473.29-53167.76-191198.57-187344.65
投资活动现金流入小计(万元)18819.5618283.2017035.4367989.2225122.10
投资活动现金流出小计(万元)171446.25126756.4970203.19259187.79212466.75
筹资活动产生的现金流量净额(万元)809102.04803949.50-66105.92-155059.00-150652.41
筹资活动现金流入小计(万元)1078027.321035193.79--79990.9479990.94
筹资活动现金流出小计(万元)268925.28231244.2966105.92235049.94230643.34
期末现金及现金等价物余额(万元)3976770.813554260.512363116.362423910.212145578.02
最后修改日期2025-10-282025-08-212025-04-252025-03-312024-10-24
↑返回页顶↑

转至恒瑞医药（600276）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。